Australia markets closed

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.9000-0.0600 (-2.03%)
At close: 04:00PM EDT
2.9300 +0.03 (+1.03%)
After hours: 07:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 27.26M
Enterprise value 2.17M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.42
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.18

Trading information

Stock price history

Beta (5Y monthly) 1.52
52-week change 35.07%
S&P500 52-week change 322.36%
52-week high 33.8400
52-week low 31.7200
50-day moving average 33.3090
200-day moving average 32.6065

Share statistics

Avg vol (3-month) 325.97k
Avg vol (10-day) 310.45k
Shares outstanding 59.4M
Implied shares outstanding 69.4M
Float 86.29M
% held by insiders 116.02%
% held by institutions 112.13%
Shares short (15 Apr 2024) 43.82k
Short ratio (15 Apr 2024) 40.12
Short % of float (15 Apr 2024) 40.05%
Short % of shares outstanding (15 Apr 2024) 40.04%
Shares short (prior month 15 Mar 2024) 46.59k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 310 July 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-7.92%
Return on equity (ttm)-48.05%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.21M
Net income avi to common (ttm)-38.77M
Diluted EPS (ttm)-5.6800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.11M
Total cash per share (mrq)2.67
Total debt (mrq)24k
Total debt/equity (mrq)0.04%
Current ratio (mrq)15.19
Book value per share (mrq)6.88

Cash flow statement

Operating cash flow (ttm)-13.57M
Levered free cash flow (ttm)-7.84M